Sensei Biotherapeutics, Inc.
SNSE
$0.3857
-$0.0192-4.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.13% | -1.55% | 10.64% | -7.80% | -4.07% |
| Total Depreciation and Amortization | -0.30% | 1.22% | -0.91% | 0.61% | -0.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 64.74% | -9.50% | -36.35% | 11.35% | 14.76% |
| Change in Net Operating Assets | -58.54% | 609.41% | 105.96% | -256.75% | -140.86% |
| Cash from Operations | -5.89% | 5.56% | 23.95% | -23.58% | -32.22% |
| Capital Expenditure | -- | 100.00% | -194.59% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -124.40% | 84.06% | 20.82% | -29.71% | -0.60% |
| Cash from Investing | -124.40% | 86.97% | 19.71% | -30.16% | -0.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.47% | -1.49% | -1.01% | -1.53% | -3.16% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | 96.03% | 89.25% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.90% | -13.33% | 13.88% | 51.51% | 82.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -226.20% | 674.33% | 145.50% | -223.20% | 49.33% |